IDH3A
Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial
Also known as: IDH3A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P50213
- Gene
- IDH3A
- Ensembl
- ENSG00000166411
- Chromosome
- 15
- Canonical length
- 366 aa
- Protein class
- Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit. The protein encoded by this gene is the alpha subunit of one isozyme of NAD(+)-dependent isocitrate dehydrogenase. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
366 residues, UniProt reviewed canonical sequence.
>P50213|IDH3A
1 MAGPAWISKV SRLLGAFHNP KQVTRGFTGG VQTVTLIPGD GIGPEISAAV MKIFDAAKAP
61 IQWEERNVTA IQGPGGKWMI PSEAKESMDK NKMGLKGPLK TPIAAGHPSM NLLLRKTFDL
121 YANVRPCVSI EGYKTPYTDV NIVTIRENTE GEYSGIEHVI VDGVVQSIKL ITEGASKRIA
181 EFAFEYARNN HRSNVTAVHK ANIMRMSDGL FLQKCREVAE SCKDIKFNEM YLDTVCLNMV
241 QDPSQFDVLV MPNLYGDILS DLCAGLIGGL GVTPSGNIGA NGVAIFESVH GTAPDIAGKD
301 MANPTALLLS AVMMLRHMGL FDHAARIEAA CFATIKDGKS LTKDLGGNAK CSDFTEEICR
361 RVKDLDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IDH3A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 93 nTPM
Expression across tissuesHPA
Tissue
- tongue: 93 nTPM
- skeletal muscle: 75 nTPM
- heart muscle: 59 nTPM
- parathyroid gland: 51 nTPM
- duodenum: 34 nTPM
- small intestine: 34 nTPM
Single-cell type
- pdcs: 206 nCPM
- cardiomyocytes: 135 nCPM
- syncytiotrophoblasts: 110 nCPM
- cone photoreceptor cells: 99 nCPM
- thymic myoid cells: 88 nCPM
- sertoli cells: 87 nCPM
Immune cell
- plasmacytoid DC: 144 nTPM
- non-classical monocyte: 54 nTPM
- intermediate monocyte: 53 nTPM
- myeloid DC: 43 nTPM
- naive B-cell: 32 nTPM
- classical monocyte: 27 nTPM
Brain region
- choroid plexus: 83 nTPM
- cerebral cortex: 75 nTPM
- cerebellum: 73 nTPM
- pons: 73 nTPM
- hippocampal formation: 71 nTPM
- white matter: 70 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IDH3A.
Disease | AllUniProt
Conditions IDH3A is implicated in, by any mechanism.
- Retinitis pigmentosa 90 (RP90) MIM:619007
Disease | GeneticClinVar
21 pathogenic / likely-pathogenic of 312 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Retinitis pigmentosa 90
- Ovarian serous cystadenocarcinoma
- Retinal dystrophy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.55
- gnomAD pLI
- 0.16
- gnomAD missense Z
- 2.59
- DepMap mean gene effect
- -0.47
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IDH3A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IDH3A as an antibody target. Whether an autoantibody or antibody against IDH3A could matter depends on whether native IDH3A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IDH3A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IDH3A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...